About Erawat Group
Erawat Group is a company based in Indore (India). It operates as a B2B. The company has 175 employees. Erawat Group offers products and services including Empty Hard Gelatin Capsules, HPMC Capsules, and Capsule Manufacturing Machines. Erawat Group operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Indore, India
- Employees 175
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Website erawatgroup.com
- Legal Name Erawat Pharma Limited
- Date of Incorporation 01 Mar, 1993
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹78.37 Cr
FY 2025 · +14% YoY
- Net Loss-₹2.51 Cr
FY 2025 · -3% margin
- EBITDA₹3.24 Cr
FY 2025 · 4% margin
- Employee Count175
Associated legal entities of Erawat Group
Erawat Group operates through Erawat Pharma Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Erawat Pharma Limited CIN U02423MP1993PLC007538 | Active | 01 Mar 1993 | Indore, Madhya Pradesh | ₹78.4 Cr | 175 | 7 | View details |
Products & Services of Erawat Group
Erawat Group offers a comprehensive portfolio of products and services, including Empty Hard Gelatin Capsules, HPMC Capsules, and Capsule Manufacturing Machines.
Capsules for medication packaging in various sizes.
Vegetable-based capsules for diverse applications.
Machines for producing hard capsules at high speeds.
Board of directors of Erawat Pharma Limited (Erawat Group)
Erawat Pharma Limited is the primary company behind Erawat Group. The board of Erawat Pharma Limited currently have 7 directors; the longest-serving is Hemchandra Jain, appointed in 1993. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hemchandra Jain DIN 00051967 | Managing Director | 01 Mar 1993 | 33 yrs 7 mo | Erawat Pharma Limited |
| Vasant Raj Solanki DIN 02438562 | Director | 16 Aug 1994 | 32 yrs 1 mo | Erawat Pharma Limited |
| Devindar Singh Sodhi DIN 02418573 | Director | 30 Apr 1997 | 29 yrs 5 mo | Erawat Pharma Limited |
| Abhishek Jain DIN 00969226 | Whole-time director | 11 Jul 2003 | 23 yrs 3 mo | Erawat Pharma Limited |
| Amit Jain DIN 00804067 | Whole-time director | 01 Oct 2018 | 8 yrs | Erawat Pharma Limited |
| Abhijeet Jain DIN 00958032 | Whole-time director | 01 Oct 2018 | 8 yrs | Erawat Pharma Limited |
| Meena Jain DIN 00052020 | Director | 15 Jun 2021 | 5 yrs 3 mo | Erawat Pharma Limited |
Financials of Erawat Group
Figures of Erawat Pharma Limited, the primary company behind Erawat Group, for FY 2025. Revenue was ₹78.37 Cr (+14% year on year). Net loss was -₹2.51 Cr (-3% margin). EBITDA was ₹3.24 Cr (4% margin). Revenue has grown at a compounded annual rate of +2% over three years and +12% over five years.
- ₹78.37 CrRevenue · FY 2025 · +14% YoY
- -₹2.51 CrNet loss · -3% margin
- ₹3.24 CrEBITDA · 4% margin
- ₹6.75 CrPaid-up capital
- 175Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Erawat Pharma Limited are on its company page.
Detailed financial statements for Erawat Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Erawat Group
Erawat Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Erawat Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Erawat Group
Complete news archive for Erawat Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Erawat Group
10 companies that operate in the same segment as Erawat Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Erawat Group
Erawat Group is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Erawat Group has 175 employees.
The primary company behind Erawat Group, Erawat Pharma Limited, reported revenue of ₹78.37 Cr for FY 2025, up 14% year on year.
ERAWAT GROUP is a manufacturer of hard capsule manufacturing machines and empty gelatin and HPMC capsules, established in 1986. They produce various sizes of capsules suitable for high-speed filling machines up to 175,000 capsules per hour. The company offers turnkey projects for capsule manufacturing and has extensive experience in India and abroad. They focus on quality products like API, DPI, and preservative-free capsules, serving industrial clients in the pharmaceutical sector.
Erawat Group's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Erawat Group offers Empty Hard Gelatin Capsules, HPMC Capsules, and Capsule Manufacturing Machines.
Erawat Group operates through Erawat Pharma Limited.
The legal entities of Erawat Group currently have 7 directors, including Amit Jain, Vasant Raj Solanki, Devindar Singh Sodhi and others.